Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Dow
AstraZeneca
Mallinckrodt
Colorcon

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR VIIBRYD


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Viibryd

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01473381 ↗ Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
NCT01473394 ↗ Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major depressive disorder.
NCT01573598 ↗ Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2012-04-01 Safety and Efficacy of Vilazodone in Major Depressive Disorder
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Viibryd

Condition Name

Condition Name for Viibryd
Intervention Trials
Major Depressive Disorder 9
Memory Impairment 1
Separation Anxiety Disorder 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Viibryd
Intervention Trials
Depressive Disorder, Major 10
Depressive Disorder 10
Depression 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Viibryd

Trials by Country

Trials by Country for Viibryd
Location Trials
United States 134
Ukraine 5
Serbia 4
Canada 4
Germany 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Viibryd
Location Trials
Florida 7
Texas 7
New York 7
California 7
Massachusetts 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Viibryd

Clinical Trial Phase

Clinical Trial Phase for Viibryd
Clinical Trial Phase Trials
Phase 4 7
Phase 3 4
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Viibryd
Clinical Trial Phase Trials
Completed 13
Terminated 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Viibryd

Sponsor Name

Sponsor Name for Viibryd
Sponsor Trials
Forest Laboratories 13
New York State Psychiatric Institute 1
Duke University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Viibryd
Sponsor Trials
Industry 13
Other 9
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
McKesson
Johnson and Johnson
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.